Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2004-07-16
2010-10-05
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S200100, C424S192100, C424S234100, C424S184100, C424S236100, C424S832000, C424S241100, C514S002600, C530S350000, C530S825000
Reexamination Certificate
active
07807184
ABSTRACT:
The present invention relates to a hybrid bacterial toxin subunit, to a hybrid bipartite bacterial toxin and to nucleic acid molecules comprising a nucleotide sequence encoding such bacterial toxins. Furthermore, the invention relates to vaccines comprising bacterial toxins and to their use in vaccines. Finally, the invention relates to methods for the preparation of such vaccines and to the use of such bacterial toxins for the manufacture of such vaccines.
REFERENCES:
patent: 6019973 (2000-02-01), Holmgren et al.
patent: 1 057 895 (2001-12-01), None
patent: WO 01/70945 (2001-09-01), None
patent: WO 01/89456 (2001-11-01), None
Abhineet S. Sheoran et al., Stx2-Specific Human Monoclonal . . . , Infection and Immunity, Jun. 2003, p. 3125-3130, vol. 71 No. 6, American Society for Microbiology, US.
Jean Mukherjee et al., Human Stx2-Specific Monoclonal Antibodies . . . , Infection and Immunity, Feb. 2002, p. 612-619, vol. 70 No. 2, American Society for Microbiology, US.
David L. MacLeod et al., Purification and Characterization of an . . . , Infection and Immunity, May 1990, p. 1232-1239, vol. 58 No. 5, American Society for Microbiology, US.
Frances Pouch Downes et al., Affinity Purification and Characterization . . . , Infection and Immunity, Aug. 1988, p. 1926-1933, vol. 56 No. 8, American Society for Microbiology.
B. Wolfanger Belisle et al., Monoclonal Antibodies . . . , Infection and Immunity, Dec. 1984, p. 759-764, vol. 46 No. 3, American Society for Microbiology, US.
B. Wolfanger Belisle et al., Characterization of Monoclonal . . . , Infection and Immunity, Mar. 1984, p. 1027-1032, vol. 43 No. 3, American Society for Microbiology, US.
Claudia Jemal et al., Analysis of Shiga Toxin . . . , Journal of Bacteriology, Jun. 1995, p. 3128-3132, vol. 177 No. 11, American Society for Microbiology, US.
Angela R. Melton-Celsa et al., Activation of Shiga toxin . . . , Molecular Microbiology, 2002, p. 207-215, vol. 43 No. 1, Blackwell Science, Ltd.
Chiara Rodighiero et al., Structural Basis for . . . , The J. of Biological Chemistry, Feb. 12, 1999, p. 3962-3969, vol. 274 No. 7, Amer. Soc. for Biochemistry and Molecular Bio.
Michael Martin et al., Recombinant Antigen-Exterotoxin . . . , Infection and Immunity, Jan. 2001, p. 252-261, vol. 69 No. 1, American Society for Microbiology, US.
Michael G. Jobling et al., Fusion Proteins Containing . . . , Infection and Immunity, Nov. 1992, p. 4915-4924, vol. 60 No. 11, American Society for Microbiology, US.
Ethan A. Merritt et al., AB5 Toxins . . . Current Opinion in Structural Biology, 1995, p. 165-171, vol. 5, Current Biology Ltd.
James C. Paton et al., Pathogenesis and Diagnosis . . . , Clinical Micro. Reviews, Jul. 1998, p. 450-479, vol. 11 No. 3, American Society for Microbiology, US.
M. Lebens et al., Synthesis of Hybrid Molecules . . . , Infection and Immunity, Jun. 1996, p. 2144-2150, vol. 64 No. 6, American Society for Microbiology, US.
Blackstone William M.
Devi S.
Interuet International B.V.
Schwartz Aaron L.
LandOfFree
Hybrid Shiga-like toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid Shiga-like toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid Shiga-like toxin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4236290